Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China
· Delayed Price · Currency is CNY 4.000
-0.030 (-0.74%)
Mar 11, 2026, 3:00 PM CST
SHA:600594 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 593.7 | 521.01 | 699.47 | 592.36 | 379.63 | 617.43 | Upgrade
|
| Short-Term Investments | - | 20 | - | - | - | 100.88 | Upgrade
|
| Cash & Short-Term Investments | 593.7 | 541.01 | 699.47 | 592.36 | 379.63 | 718.31 | Upgrade
|
| Cash Growth | -4.22% | -22.66% | 18.08% | 56.04% | -47.15% | -32.60% | Upgrade
|
| Accounts Receivable | 378.55 | 528.94 | 692.32 | 722.23 | 698.66 | 976.28 | Upgrade
|
| Other Receivables | 30.8 | 38.88 | 53.84 | 56.42 | 38.42 | 42.48 | Upgrade
|
| Receivables | 409.35 | 567.82 | 746.16 | 778.65 | 737.07 | 1,019 | Upgrade
|
| Inventory | 545.5 | 607.77 | 586.65 | 625.08 | 554.63 | 498.36 | Upgrade
|
| Other Current Assets | 81.47 | 33.43 | 36.87 | 44.54 | 48.65 | 48.75 | Upgrade
|
| Total Current Assets | 1,630 | 1,750 | 2,069 | 2,041 | 1,720 | 2,284 | Upgrade
|
| Property, Plant & Equipment | 1,523 | 1,648 | 1,755 | 1,827 | 1,709 | 1,419 | Upgrade
|
| Long-Term Investments | 35.99 | 36.41 | 36.66 | 37.46 | 38.27 | 41.16 | Upgrade
|
| Goodwill | 131.26 | 131.26 | 164.04 | 164.04 | 777.66 | 631.73 | Upgrade
|
| Other Intangible Assets | 309.7 | 319.56 | 330.89 | 362.03 | 378.54 | 341.97 | Upgrade
|
| Long-Term Deferred Tax Assets | 100.7 | 90.34 | 55.58 | 229.96 | 202.28 | 191.32 | Upgrade
|
| Long-Term Deferred Charges | 89.96 | 103.47 | 123.13 | 145.72 | 169.81 | 172.7 | Upgrade
|
| Other Long-Term Assets | 17.23 | 20.58 | 62.42 | 63.17 | 72.4 | 144.16 | Upgrade
|
| Total Assets | 3,838 | 4,100 | 4,597 | 4,870 | 5,068 | 5,226 | Upgrade
|
| Accounts Payable | 91.68 | 117.98 | 124.54 | 133.25 | 108.47 | 84.72 | Upgrade
|
| Accrued Expenses | 36.12 | 57.79 | 72.43 | 103.61 | 86.57 | 86.39 | Upgrade
|
| Short-Term Debt | 413.89 | 380.93 | 446.05 | 537.11 | 454.45 | 745.55 | Upgrade
|
| Current Portion of Long-Term Debt | 202.01 | 227.68 | 115.05 | 162.15 | 120.15 | 345 | Upgrade
|
| Current Portion of Leases | - | 8.98 | 13.97 | 15.37 | 9.16 | 9.15 | Upgrade
|
| Current Income Taxes Payable | 24.37 | 8.85 | 7.54 | 21.07 | 47.42 | 41.98 | Upgrade
|
| Current Unearned Revenue | 21.01 | 27.12 | 29.52 | 67.51 | 54.15 | 23.05 | Upgrade
|
| Other Current Liabilities | 79.34 | 119.68 | 120.49 | 132.64 | 199.01 | 200.21 | Upgrade
|
| Total Current Liabilities | 868.44 | 949.01 | 929.59 | 1,173 | 1,079 | 1,536 | Upgrade
|
| Long-Term Debt | 229.56 | 307.52 | 387.22 | 343.04 | 315.93 | 94.38 | Upgrade
|
| Long-Term Leases | 20.65 | 26.78 | 30.36 | 29.3 | 12.41 | - | Upgrade
|
| Long-Term Unearned Revenue | 90.78 | 94.64 | 106.31 | 100.18 | 67.6 | 41.38 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 33.24 | 34.74 | 37.44 | 33.9 | 30.26 | 25.69 | Upgrade
|
| Other Long-Term Liabilities | 80.06 | 80.9 | 88.07 | 0.65 | - | 65.75 | Upgrade
|
| Total Liabilities | 1,323 | 1,494 | 1,579 | 1,680 | 1,506 | 1,763 | Upgrade
|
| Common Stock | 791.93 | 791.93 | 791.93 | 791.93 | 791.93 | 791.93 | Upgrade
|
| Additional Paid-In Capital | 653.84 | 653.84 | 653.84 | 733.84 | 766.15 | 768.39 | Upgrade
|
| Retained Earnings | 981.99 | 1,069 | 1,438 | 1,518 | 1,944 | 1,803 | Upgrade
|
| Treasury Stock | -25 | -25 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 0.43 | 0.45 | 0.65 | 0.99 | 1.19 | 1.73 | Upgrade
|
| Total Common Equity | 2,403 | 2,490 | 2,884 | 3,044 | 3,503 | 3,365 | Upgrade
|
| Minority Interest | 112.28 | 116.35 | 133.81 | 145.85 | 59.25 | 97.96 | Upgrade
|
| Shareholders' Equity | 2,515 | 2,606 | 3,018 | 3,190 | 3,562 | 3,463 | Upgrade
|
| Total Liabilities & Equity | 3,838 | 4,100 | 4,597 | 4,870 | 5,068 | 5,226 | Upgrade
|
| Total Debt | 866.11 | 951.89 | 992.65 | 1,087 | 912.11 | 1,194 | Upgrade
|
| Net Cash (Debt) | -272.42 | -410.88 | -293.18 | -494.6 | -532.48 | -475.77 | Upgrade
|
| Net Cash Per Share | -0.35 | -0.52 | -0.37 | -0.62 | -0.67 | -0.60 | Upgrade
|
| Filing Date Shares Outstanding | 784.39 | 784.39 | 791.93 | 791.93 | 791.93 | 791.93 | Upgrade
|
| Total Common Shares Outstanding | 784.39 | 784.39 | 791.93 | 791.93 | 791.93 | 791.93 | Upgrade
|
| Working Capital | 761.57 | 801.01 | 1,140 | 867.92 | 640.59 | 748.12 | Upgrade
|
| Book Value Per Share | 3.06 | 3.17 | 3.64 | 3.84 | 4.42 | 4.25 | Upgrade
|
| Tangible Book Value | 1,962 | 2,039 | 2,390 | 2,518 | 2,347 | 2,391 | Upgrade
|
| Tangible Book Value Per Share | 2.50 | 2.60 | 3.02 | 3.18 | 2.96 | 3.02 | Upgrade
|
| Buildings | - | 1,911 | 1,865 | 1,686 | 1,326 | 1,266 | Upgrade
|
| Machinery | - | 924.43 | 933.15 | 906.77 | 809.92 | 699.97 | Upgrade
|
| Construction In Progress | - | 0.7 | 4.99 | 145.94 | 472.4 | 240.49 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.